FindTrial
Sign In

Respiratory outcome in COVID-19 patients at 3 month and 6 month of discharge

A Follow Up Study Of Pulmonary Sequelae In Patients Diagnosed With COVID- 19 In A Tertiary Care Centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039639
Enrollment
100
Registered
2022-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr D Y Patil Medical College Hospital and Research Centre Dr D Y Patil Vidyapeeth Pimpri Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All rt-PCR confirmed diagnosed cases of COVID-19 above 18 years of age and whose CT severity index is more than 13/40.

Exclusion criteria

Exclusion criteria: 1. All patients with known lung disease (eg. COPD, Bronchiectasis, ILD) 2. Autoimmune disease RA, SLE, Systemic sclerosis, Sjogren syndrome, MCTD, myositis on history and relevant investigation based on history 3. Smokers and those with occupational exposures 4. Use of inhalers or bronchodilators in past

Design outcomes

Primary

MeasureTime frame
correlate radiological findings,the clinical features and laboratory findings at presentation, with radiological findings,clinical features and pulmonary function tests at 3 and 6 months, and find predictive factors for lung sequelae.Timepoint: 3 month and 6 month—

Secondary

MeasureTime frame
IgG antibody titre at 3 and 6 monthsTimepoint: 3 months & 6 months—

Countries

India

Contacts

Public ContactDr Varsha R Bhatt

Dr D Y Patil Medical College Hospital and Research Centre, Pimpri ,Pune

drvrbhatt@gmail.com9405580574

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026